Literature DB >> 20661789

HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

Gambo Aliyu1, Mukhtar Mohammad, Ahmed Saidu, Prosanta Mondal, Man Charurat, Alash'le Abimiku, Abdulsalami Nasidi, William Blattner.   

Abstract

The purpose of this survey is to generate baseline data on the level of HIV infection awareness and willingness to participate (WTP) in hypothetical vaccine trials, ahead of any trial conduct in Nigeria. In a cross-sectional survey, 500 respondents were interviewed, including sex workers, male motorcycle taxi drivers, students, and the general public. About 153 (30.6%) of the respondents did not believe that correct and consistent use of condom can protect people from getting HIV, while about 66 (13.2%) respondents believed it is possible to get HIV by sharing meal with an infected person. Population groups considered at high risk for HIV were less aware of the disease, however, they were more willing to participate in HIV vaccine trials compared those at low risk of the disease. A total of 55% expressed WTP in a hypothetical vaccine trial after they were informed about it. Age, population group, and ethnicity were significantly associated with WTP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20661789      PMCID: PMC2982143          DOI: 10.1080/09540121003692219

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  36 in total

1.  HIV/AIDS awareness and sexual practices among undergraduates in Enugu, Nigeria.

Authors:  H E Onah; A U Mbah; J C Chukwuka; A C C Ikeme
Journal:  Niger Postgrad Med J       Date:  2004-06

2.  Local knowledge and experiences of vaccination: implications for HIV-preventive vaccine trials in South Africa.

Authors:  Graham Lindegger; Michael Quayle; Moses Ndlovu
Journal:  Health Educ Behav       Date:  2006-05-31

3.  KAP of HIV prevention and screening among pregnant women attending specialist antenatal clinics in Calabar, Nigeria.

Authors:  J E Ekabua; A E Oyo-Ita; D S Ogaji; V O Omuemu
Journal:  Niger J Med       Date:  2006 Oct-Dec

4.  Willingness to participate in HIV vaccine research in a peri-urban South African community.

Authors:  J Smit; K Middelkoop; L Myer; S Seedat; L-G Bekker; D J Stein
Journal:  Int J STD AIDS       Date:  2006-03       Impact factor: 1.359

5.  Awareness and attitude of antenatal clients towards HIV voluntary counselling and testing in Aminu Kano Teaching Hospital, Kano, Nigeria.

Authors:  Z Iliyasu; M Kabir; H S Galadanci; I S Abubakar; M H Aliyu
Journal:  Niger J Med       Date:  2005 Jan-Mar

6.  Subgroup G HIV type 1 isolates from Nigeria.

Authors:  A G Abimiku; T L Stern; A Zwandor; P D Markham; C Calef; S Kyari; W C Saxinger; R C Gallo; M Robert-Guroff; M S Reitz
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

7.  Nigerian HIV type 2 subtype A and B from heterotypic HIV type 1 and HIV type 2 or monotypic HIV type 2 infections.

Authors:  Clement Zeh; Danuta Pieniazek; Simon M Agwale; Kenneth E Robbins; Lillian Odama; N Sani-Gwarzo; Michael S Gboun; Uford S Inyang; Thomas M Folks; Charles Wambebe; Marcia L Kalish
Journal:  AIDS Res Hum Retroviruses       Date:  2005-01       Impact factor: 2.205

8.  Willingness to participate in HIV vaccine trials among HIV-negative gay men in Sydney, Australia.

Authors:  Paul Van de Ven; Limin Mao; June Crawford; Garrett Prestage; Andrew Grulich; John Kaldor; Susan Kippax
Journal:  Int J STD AIDS       Date:  2005-04       Impact factor: 1.359

9.  A pilot study on willingness to participate in future preventive HIV vaccine trials.

Authors:  Mohanarani Suhadev; Adeline M Nyamathi; Soumya Swaminathan; P Venkatesan; M Raja Sakthivel; R Shenbagavalli; Anitha Suresh; John L Fahey
Journal:  Indian J Med Res       Date:  2006-12       Impact factor: 2.375

10.  Awareness, attitudes, and beliefs of the general public towards HIV/AIDS in Hyderabad, a capital city from South India.

Authors:  R T Sudha; D T Vijay; V Lakshmi
Journal:  Indian J Med Sci       Date:  2005-07
View more
  11 in total

1.  Factors influencing mothers' decision to enroll their HIV-negative children in a hypothetical HIV vaccine trial.

Authors:  Victoria Williamson; Bronwyne Coetzee; Ashraf Kagee; Mark Tomlinson
Journal:  Future Virol       Date:  2016-12-21       Impact factor: 1.831

2.  Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.

Authors:  T Kufa; V Chihota; S Charalambous; S Verver; G Churchyard
Journal:  Public Health Action       Date:  2013-03-21

3.  Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial.

Authors:  Barbara S Mensch; Barbara A Friedland; Sharon A Abbott; Lauren L Katzen; Waimar Tun; Christine A Kelly; Avina Sarna; Aylur K Srikrishnan; Suniti Solomon
Journal:  AIDS Behav       Date:  2013-02

4.  High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.

Authors:  Noah Kiwanuka; Ali Ssetaala; Juliet Mpendo; Matthias Wambuzi; Annet Nanvubya; Simon Sigirenda; Annet Nalutaaya; Paul Kato; Leslie Nielsen; Pontiano Kaleebu; Josephine Nalusiba; Nelson K Sewankambo
Journal:  J Int AIDS Soc       Date:  2013-07-22       Impact factor: 5.396

5.  Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.

Authors:  M Florencia Etcheverry; Jennifer L Evans; Emilia Sanchez; Eva Mendez-Arancibia; Mercé Meroño; José M Gatell; Kimberly Page; Joan Joseph
Journal:  Hum Vaccin Immunother       Date:  2013-01-04       Impact factor: 3.452

6.  Trends and determinants of HIV/AIDS knowledge among women in Bangladesh.

Authors:  Sanni Yaya; Ghose Bishwajit; Georges Danhoundo; Vaibhav Shah; Michael Ekholuenetale
Journal:  BMC Public Health       Date:  2016-08-17       Impact factor: 3.295

7.  Willingness to Participate in Hypothetical HIV Vaccine Trial and Associated Factors among People Who Inject Drugs in Dar es Salaam, Tanzania.

Authors:  Masunga K Iseselo; Edith A M Tarimo; Eric Sandstrom; Asli Kulane
Journal:  Biomed Res Int       Date:  2020-07-02       Impact factor: 3.411

8.  Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.

Authors:  Gershim Asiki; Andrew Abaasa; Eugene Ruzagira; Freddie Kibengo; Ubaldo Bahemuka; Jerry Mulondo; Janet Seeley; Linda-Gail Bekker; Sinead Delany; Pontiano Kaleebu; Anatoli Kamali
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

9.  An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.

Authors:  Ogbonnaya S Njoku; Mark M Manak; Robert J O'Connell; Ashley L W Shutt; Jennifer A Malia; Richard A Heipertz; Sodsai Tovanabutra; Mark J Milazzo; Gideon Akindiran Akintunde; Abraham S Alabi; Aminu Suleiman; Amos A Ogundeji; Terfa S Kene; Robbie Nelson; Ojor R Ayemoba; Darrell E Singer; Merlin L Robb; Sheila A Peel; Nelson L Michael
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

10.  Factors associated with knowledge and awareness of HIV/AIDS among married women in Bangladesh: evidence from a nationally representative survey.

Authors:  Md Ashiqul Haque; Md Sha Newaj Hossain; Muhammad Abdul Baker Chowdhury; Md Jamal Uddin
Journal:  SAHARA J       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.